0
0
MUMBAI — For millions of couples in India, the dream of parenthood is coming with a price tag so high it threatens to push them into financial ruin. A landmark study by the Indian Council of Medical Research (ICMR) has revealed that nearly 90% of couples undergoing In Vitro Fertilization (IVF) face “catastrophic health expenditure,” spending significantly more than their annual household income can sustain.
The report, conducted by the ICMR-National Institute for Research in Reproductive and Child Health (NIRRCH), provides the first comprehensive empirical evidence of the economic toxicity associated with infertility treatment in India. Released this week, the findings have ignited urgent calls for infertility treatments to be included in national health insurance schemes like the Pradhan Mantri Jan Arogya Yojana (PM-JAY).
The High Price of Hope
Infertility, often stigmatized and suffered in silence, is a growing public health concern affecting an estimated 28 million couples in India. While medical science offers solutions, they remain tantalizingly out of reach for the majority.
The study, which surveyed couples across public and private healthcare facilities, painted a stark picture of the financial reality. The researchers defined “catastrophic health expenditure” as health spending that exceeds 10% of a household’s total annual income—a threshold that forces families to cut back on basic necessities, borrow money, or sell assets.
Key Economic Findings:
-
Catastrophic Impact: While 25% of couples seeking general infertility care faced catastrophic expenses, this number skyrocketed to 85% for those requiring IVF.
-
Public vs. Private Disparity: Even in public hospitals, where services are subsidized, the average out-of-pocket expenditure (OOPE) for a single IVF cycle was found to be ₹1.1 lakh. In private hospitals, this figure more than doubles to approximately ₹2.38 lakh per cycle.
-
The Multiplier Effect: These costs represent only a single cycle. With global success rates for IVF hovering between 30-40%, most couples require multiple cycles to achieve a successful pregnancy, compounding the financial burden.
“The data confirms what clinicians have witnessed for years: the financial stress of treatment is often as debilitating as the medical condition itself,” says Dr. Anjali Kumar, a senior fertility specialist in New Delhi (name changed for anonymity). “We see patients mortgaging jewelry or taking high-interest loans just for a chance to conceive. It transforms a medical necessity into a luxury good.”
The ‘OPD’ Loophole
One of the study’s most critical insights is the structural gap in current insurance coverage. The majority of infertility treatment costs are incurred in the Outpatient Department (OPD)—including expensive hormonal injections, repeated ultrasounds, and diagnostic tests.
Currently, India’s flagship health assurance scheme, PM-JAY (Ayushman Bharat), primarily covers hospitalization expenses (inpatient care). Since IVF is largely an OPD-based procedure, it falls outside the safety net of government aid, leaving the poorest families to bear 100% of the cost.
“Currently, OPD expenses are not covered under PM-JAY,” the ICMR report noted. “As the majority of expenditure for infertility treatment, including IVF, is OPD-based, this consideration needs to be made for including IVF in the PM-JAY package.”
A Policy Prescription
The ICMR-NIRRCH report does not just diagnose the problem; it offers a calculated solution. The researchers estimated the “health system cost”—the actual cost to the provider—for one IVF cycle to be ₹81,332.
Based on this, the study recommends a specific package rate for inclusion in public health programs:
-
₹81,332 reimbursement for the first IVF cycle.
-
₹35,087 for subsequent cycles.
If implemented, this would require an estimated budget of roughly ₹2,703 crores to cover the first cycle for eligible women across India. While a significant sum, experts argue it is a necessary investment in reproductive rights and population health.
Independent experts have welcomed the proposal. Dr. Shobhit Agarwal, CEO of Nova IVF Fertility, noted in recent coverage that including fertility treatments in PM-JAY would “reduce the emotional and financial burden” and democratize access to essential care.
The Human Cost
Behind the statistics are human stories of despair and resilience. Infertility in India is not merely a medical condition but a social one, often carrying immense stigma, particularly for women.
The study highlighted that 46% of infertility cases were attributed to female factors (such as Polycystic Ovarian Syndrome or tubal blockages), 20% to male factors, and the remainder to combined or unexplained causes.
For families in lower-income brackets, the inability to access treatment due to cost can lead to social ostracization, mental health struggles, and marital breakdown. By making treatment unaffordable, the healthcare system effectively denies these couples the right to a family based solely on their economic status.
Challenges Ahead
While the recommendation to include IVF in PM-JAY is a hopeful step, implementation faces hurdles.
-
Infrastructure: Public sector capacity for advanced Assisted Reproductive Technology (ART) is currently limited. Most ART centers are private and concentrated in urban metros.
-
Regulation: The private sector is vast and variable in its pricing. Bringing private clinics under a government reimbursement cap of ₹81,000—when they currently charge upwards of ₹2 lakh—will require robust negotiation and regulatory oversight.
-
Success Rates: Unlike a surgery that fixes a problem definitively, IVF is a game of probabilities. Policymakers will need to decide how many cycles the state can afford to subsidize per couple.
Conclusion
The ICMR-NIRRCH study serves as a wake-up call for Indian healthcare policy. In a country where family is the cornerstone of social structure, the inability to conceive is a profound crisis. By quantifying the “catastrophic” cost of this crisis, the medical community has laid the groundwork for a policy shift that could finally put the dream of parenthood within reach of the common citizen.
Medical Disclaimer:
This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.
References
-
Primary Study: Indian Council of Medical Research – National Institute for Research in Reproductive and Child Health (ICMR-NIRRCH). Cost of Infertility Treatment and Prevalence of Catastrophic Health Expenditure in India. (2025).
